Caseware UK (AP4) 2023.0.135 2023.0.135 2023-12-312023-12-31falsetrueNo description of principal activityfalse2023-01-06false6The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 14574660 2023-01-05 14574660 2023-01-06 2023-12-31 14574660 2022-01-06 2023-01-05 14574660 2023-12-31 14574660 c:Director1 2023-01-06 2023-12-31 14574660 c:Director1 2023-12-31 14574660 c:Director2 2023-01-06 2023-12-31 14574660 c:Director2 2023-12-31 14574660 c:RegisteredOffice 2023-01-06 2023-12-31 14574660 d:CurrentFinancialInstruments 2023-12-31 14574660 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 14574660 d:ShareCapital 2023-01-06 2023-12-31 14574660 d:ShareCapital 2023-12-31 14574660 d:RetainedEarningsAccumulatedLosses 2023-01-06 2023-12-31 14574660 d:RetainedEarningsAccumulatedLosses 2023-12-31 14574660 c:FRS102 2023-01-06 2023-12-31 14574660 c:AuditExempt-NoAccountantsReport 2023-01-06 2023-12-31 14574660 c:FullAccounts 2023-01-06 2023-12-31 14574660 c:PrivateLimitedCompanyLtd 2023-01-06 2023-12-31 14574660 e:PoundSterling 2023-01-06 2023-12-31 iso4217:GBP xbrli:pure
Registered number: 14574660















SURGO HEALTH UK LIMITED
UNAUDITED
FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023



























 
SURGO HEALTH UK LIMITED
 
 
COMPANY INFORMATION


Directors
Mala Gopal Gaonkar (appointed 6 January 2023)
Sema Khairi Sgaier (appointed 6 January 2023)




Registered number
14574660



Registered office
3rd Floor
12 Gough Square

London

EC4A 3DW





 
SURGO HEALTH UK LIMITED
REGISTERED NUMBER: 14574660

BALANCE SHEET
AS AT 31 DECEMBER 2023

2023
Note
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
100

Cash at bank and in hand
  
238,259

  
238,359

Creditors: amounts falling due within one year
 5 
(217,575)

Net current assets
  
 
 
20,784

Total assets less current liabilities
  
20,784

  

Net assets
  
20,784


Capital and reserves
  

Called up share capital 
  
100

Profit and loss account
  
20,684

  
20,784


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 6 September 2024.




Sema Khairi Sgaier
Director

The notes on pages 3 to 7 form part of these financial statements.

Page 1

 
SURGO HEALTH UK LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 31 DECEMBER 2023


Called up share capital
Profit and loss account
Total equity

£
£
£


Comprehensive income for the period

Profit for the period
-
20,684
20,684
Total comprehensive income for the period
-
20,684
20,684


Contributions by and distributions to owners

Shares issued during the period
100
-
100


At 31 December 2023
100
20,684
20,784

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
SURGO HEALTH UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

1.


General information

Surgo Health UK Limited is a private limited company, incorporated in the United Kingdom and registered in England and Wales. The Company's registered office address is 3rd Floor, 12 Gough Square, London, EC4A 3DW.

The company was incorporated on 6 January 2023 and has prepared financial statements for the period to 31 December 2023.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Turnover

Turnover represents fees receivable for administrative support services provided during the year. Turnover is recognised when the services have been provided and is measured at a mark-up on costs in line with the Administrative Service Agreement.

 
2.3

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Page 3

 
SURGO HEALTH UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment.

 
2.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. 

 
2.7

Creditors

Short-term creditors are measured at the transaction price. 

Page 4

 
SURGO HEALTH UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

 
2.8

Financial instruments

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Page 5

 
SURGO HEALTH UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

3.


Employees

Period ended
31 December
2023
£

Wages and salaries
445,144

Social security costs
45,986

Pension costs
16,075

507,205


The average monthly number of employees, including directors, during the period was 6.


4.


Debtors

2023
£


Called up share capital not paid
100

100



5.


Creditors: Amounts falling due within one year

2023
£

Amounts owed to group undertakings
112,753

Corporation tax
5,121

Other taxation and social security
16,474

Other creditors
25,436

Accruals and deferred income
57,791

217,575



6.


Related party transactions

The company has adopted the exemption permitted by paragraph 33.1A of FRS 102 and has not disclosed transactions with other group members.

Page 6

 
SURGO HEALTH UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

7.


Controlling party

Surgo Health UK Limited is a wholly owned subsidiary of Surgo Health P.B.C. a company based in the United States of America, whose registered address is 1209 Orange Street, Wilmington, Delaware 19801.

The Ultimate controlling party of the group by virtue of shareholding is S K Sgaier.

 
Page 7